nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS1—malignant glioma	0.492	0.636	CbGaD
Etodolac—PTGS2—malignant glioma	0.281	0.364	CbGaD
Etodolac—Meningitis—Carmustine—malignant glioma	0.00395	0.0392	CcSEcCtD
Etodolac—Lung infiltration—Carmustine—malignant glioma	0.00327	0.0324	CcSEcCtD
Etodolac—Skin hyperpigmentation—Carmustine—malignant glioma	0.00258	0.0256	CcSEcCtD
Etodolac—Burning sensation—Carmustine—malignant glioma	0.00221	0.0219	CcSEcCtD
Etodolac—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00157	0.0155	CcSEcCtD
Etodolac—Hearing impaired—Temozolomide—malignant glioma	0.00156	0.0154	CcSEcCtD
Etodolac—Skin exfoliation—Carmustine—malignant glioma	0.00146	0.0145	CcSEcCtD
Etodolac—Skin exfoliation—Temozolomide—malignant glioma	0.00141	0.014	CcSEcCtD
Etodolac—Coma—Carmustine—malignant glioma	0.0014	0.0139	CcSEcCtD
Etodolac—Aplastic anaemia—Temozolomide—malignant glioma	0.00139	0.0138	CcSEcCtD
Etodolac—Sepsis—Carmustine—malignant glioma	0.00133	0.0132	CcSEcCtD
Etodolac—Deafness—Temozolomide—malignant glioma	0.0012	0.0119	CcSEcCtD
Etodolac—Vascular purpura—Temozolomide—malignant glioma	0.0012	0.0119	CcSEcCtD
Etodolac—Hepatic failure—Temozolomide—malignant glioma	0.0012	0.0119	CcSEcCtD
Etodolac—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00114	0.0113	CcSEcCtD
Etodolac—Thirst—Temozolomide—malignant glioma	0.00113	0.0112	CcSEcCtD
Etodolac—Purpura—Temozolomide—malignant glioma	0.00112	0.0111	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00111	0.011	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000968	0.00961	CcSEcCtD
Etodolac—Abdominal distension—Temozolomide—malignant glioma	0.000936	0.00929	CcSEcCtD
Etodolac—Pancytopenia—Carmustine—malignant glioma	0.000913	0.00906	CcSEcCtD
Etodolac—Neutropenia—Carmustine—malignant glioma	0.000899	0.00893	CcSEcCtD
Etodolac—Bronchitis—Temozolomide—malignant glioma	0.000894	0.00887	CcSEcCtD
Etodolac—Pancytopenia—Temozolomide—malignant glioma	0.000883	0.00876	CcSEcCtD
Etodolac—Dysuria—Temozolomide—malignant glioma	0.000869	0.00863	CcSEcCtD
Etodolac—Neutropenia—Temozolomide—malignant glioma	0.000869	0.00863	CcSEcCtD
Etodolac—Hyperglycaemia—Carmustine—malignant glioma	0.000867	0.00861	CcSEcCtD
Etodolac—Pneumonia—Carmustine—malignant glioma	0.000862	0.00856	CcSEcCtD
Etodolac—Pollakiuria—Temozolomide—malignant glioma	0.000858	0.00852	CcSEcCtD
Etodolac—Photosensitivity reaction—Temozolomide—malignant glioma	0.000848	0.00842	CcSEcCtD
Etodolac—Renal failure—Carmustine—malignant glioma	0.000843	0.00837	CcSEcCtD
Etodolac—Hyperglycaemia—Temozolomide—malignant glioma	0.000838	0.00832	CcSEcCtD
Etodolac—Stomatitis—Carmustine—malignant glioma	0.000836	0.0083	CcSEcCtD
Etodolac—Pneumonia—Temozolomide—malignant glioma	0.000833	0.00827	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000821	0.00815	CcSEcCtD
Etodolac—Stomatitis—Temozolomide—malignant glioma	0.000808	0.00802	CcSEcCtD
Etodolac—Sinusitis—Temozolomide—malignant glioma	0.000777	0.00772	CcSEcCtD
Etodolac—Haemoglobin—Carmustine—malignant glioma	0.000774	0.00768	CcSEcCtD
Etodolac—Haemorrhage—Carmustine—malignant glioma	0.00077	0.00764	CcSEcCtD
Etodolac—Hallucination—Carmustine—malignant glioma	0.000766	0.0076	CcSEcCtD
Etodolac—Haemoglobin—Temozolomide—malignant glioma	0.000748	0.00742	CcSEcCtD
Etodolac—Hepatitis—Temozolomide—malignant glioma	0.000744	0.00738	CcSEcCtD
Etodolac—Haemorrhage—Temozolomide—malignant glioma	0.000744	0.00738	CcSEcCtD
Etodolac—Visual impairment—Carmustine—malignant glioma	0.000742	0.00736	CcSEcCtD
Etodolac—Hallucination—Temozolomide—malignant glioma	0.00074	0.00735	CcSEcCtD
Etodolac—Pharyngitis—Temozolomide—malignant glioma	0.000738	0.00733	CcSEcCtD
Etodolac—Visual impairment—Temozolomide—malignant glioma	0.000717	0.00711	CcSEcCtD
Etodolac—Flushing—Carmustine—malignant glioma	0.000714	0.00709	CcSEcCtD
Etodolac—Erythema multiforme—Temozolomide—malignant glioma	0.000703	0.00698	CcSEcCtD
Etodolac—Tinnitus—Temozolomide—malignant glioma	0.000694	0.00688	CcSEcCtD
Etodolac—Flushing—Temozolomide—malignant glioma	0.00069	0.00685	CcSEcCtD
Etodolac—Arrhythmia—Carmustine—malignant glioma	0.000688	0.00682	CcSEcCtD
Etodolac—Alopecia—Carmustine—malignant glioma	0.00068	0.00675	CcSEcCtD
Etodolac—Chills—Temozolomide—malignant glioma	0.000667	0.00662	CcSEcCtD
Etodolac—Alopecia—Temozolomide—malignant glioma	0.000657	0.00652	CcSEcCtD
Etodolac—Dysgeusia—Temozolomide—malignant glioma	0.000634	0.00629	CcSEcCtD
Etodolac—Vision blurred—Carmustine—malignant glioma	0.000631	0.00627	CcSEcCtD
Etodolac—Tremor—Carmustine—malignant glioma	0.000628	0.00623	CcSEcCtD
Etodolac—Anaemia—Carmustine—malignant glioma	0.000619	0.00615	CcSEcCtD
Etodolac—Vision blurred—Temozolomide—malignant glioma	0.00061	0.00606	CcSEcCtD
Etodolac—Tremor—Temozolomide—malignant glioma	0.000607	0.00602	CcSEcCtD
Etodolac—Ill-defined disorder—Temozolomide—malignant glioma	0.000601	0.00596	CcSEcCtD
Etodolac—Leukopenia—Carmustine—malignant glioma	0.0006	0.00595	CcSEcCtD
Etodolac—Anaemia—Temozolomide—malignant glioma	0.000598	0.00594	CcSEcCtD
Etodolac—Angioedema—Temozolomide—malignant glioma	0.000592	0.00587	CcSEcCtD
Etodolac—Malaise—Temozolomide—malignant glioma	0.000584	0.0058	CcSEcCtD
Etodolac—Vertigo—Temozolomide—malignant glioma	0.000582	0.00577	CcSEcCtD
Etodolac—Convulsion—Carmustine—malignant glioma	0.000581	0.00576	CcSEcCtD
Etodolac—Leukopenia—Temozolomide—malignant glioma	0.00058	0.00575	CcSEcCtD
Etodolac—Hypertension—Carmustine—malignant glioma	0.000579	0.00574	CcSEcCtD
Etodolac—Palpitations—Temozolomide—malignant glioma	0.000572	0.00568	CcSEcCtD
Etodolac—Myalgia—Carmustine—malignant glioma	0.00057	0.00566	CcSEcCtD
Etodolac—Anxiety—Carmustine—malignant glioma	0.000568	0.00564	CcSEcCtD
Etodolac—Convulsion—Temozolomide—malignant glioma	0.000561	0.00557	CcSEcCtD
Etodolac—Hypertension—Temozolomide—malignant glioma	0.000559	0.00555	CcSEcCtD
Etodolac—Confusional state—Carmustine—malignant glioma	0.000551	0.00547	CcSEcCtD
Etodolac—Myalgia—Temozolomide—malignant glioma	0.000551	0.00547	CcSEcCtD
Etodolac—Arthralgia—Temozolomide—malignant glioma	0.000551	0.00547	CcSEcCtD
Etodolac—Anxiety—Temozolomide—malignant glioma	0.000549	0.00545	CcSEcCtD
Etodolac—Oedema—Carmustine—malignant glioma	0.000547	0.00543	CcSEcCtD
Etodolac—Discomfort—Temozolomide—malignant glioma	0.000545	0.00541	CcSEcCtD
Etodolac—Infection—Carmustine—malignant glioma	0.000543	0.00539	CcSEcCtD
Etodolac—Dry mouth—Temozolomide—malignant glioma	0.000539	0.00535	CcSEcCtD
Etodolac—Thrombocytopenia—Carmustine—malignant glioma	0.000535	0.00531	CcSEcCtD
Etodolac—Tachycardia—Carmustine—malignant glioma	0.000534	0.0053	CcSEcCtD
Etodolac—Confusional state—Temozolomide—malignant glioma	0.000533	0.00529	CcSEcCtD
Etodolac—Anaphylactic shock—Temozolomide—malignant glioma	0.000528	0.00525	CcSEcCtD
Etodolac—Oedema—Temozolomide—malignant glioma	0.000528	0.00525	CcSEcCtD
Etodolac—Infection—Temozolomide—malignant glioma	0.000525	0.00521	CcSEcCtD
Etodolac—Anorexia—Carmustine—malignant glioma	0.000521	0.00517	CcSEcCtD
Etodolac—Thrombocytopenia—Temozolomide—malignant glioma	0.000517	0.00514	CcSEcCtD
Etodolac—Hypotension—Carmustine—malignant glioma	0.000511	0.00507	CcSEcCtD
Etodolac—Hyperhidrosis—Temozolomide—malignant glioma	0.000511	0.00507	CcSEcCtD
Etodolac—Anorexia—Temozolomide—malignant glioma	0.000504	0.005	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000498	0.00495	CcSEcCtD
Etodolac—Insomnia—Carmustine—malignant glioma	0.000495	0.00491	CcSEcCtD
Etodolac—Paraesthesia—Carmustine—malignant glioma	0.000491	0.00487	CcSEcCtD
Etodolac—Dyspnoea—Carmustine—malignant glioma	0.000488	0.00484	CcSEcCtD
Etodolac—Somnolence—Carmustine—malignant glioma	0.000486	0.00483	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000481	0.00478	CcSEcCtD
Etodolac—Insomnia—Temozolomide—malignant glioma	0.000478	0.00474	CcSEcCtD
Etodolac—Decreased appetite—Carmustine—malignant glioma	0.000475	0.00472	CcSEcCtD
Etodolac—Paraesthesia—Temozolomide—malignant glioma	0.000475	0.00471	CcSEcCtD
Etodolac—Dyspnoea—Temozolomide—malignant glioma	0.000471	0.00468	CcSEcCtD
Etodolac—Somnolence—Temozolomide—malignant glioma	0.00047	0.00466	CcSEcCtD
Etodolac—Pain—Carmustine—malignant glioma	0.000468	0.00464	CcSEcCtD
Etodolac—Constipation—Carmustine—malignant glioma	0.000468	0.00464	CcSEcCtD
Etodolac—Dyspepsia—Temozolomide—malignant glioma	0.000465	0.00462	CcSEcCtD
Etodolac—Decreased appetite—Temozolomide—malignant glioma	0.000459	0.00456	CcSEcCtD
Etodolac—Fatigue—Temozolomide—malignant glioma	0.000456	0.00452	CcSEcCtD
Etodolac—Pain—Temozolomide—malignant glioma	0.000452	0.00449	CcSEcCtD
Etodolac—Constipation—Temozolomide—malignant glioma	0.000452	0.00449	CcSEcCtD
Etodolac—Feeling abnormal—Carmustine—malignant glioma	0.000451	0.00447	CcSEcCtD
Etodolac—Gastrointestinal pain—Carmustine—malignant glioma	0.000447	0.00444	CcSEcCtD
Etodolac—Feeling abnormal—Temozolomide—malignant glioma	0.000435	0.00432	CcSEcCtD
Etodolac—Abdominal pain—Carmustine—malignant glioma	0.000432	0.00429	CcSEcCtD
Etodolac—Body temperature increased—Carmustine—malignant glioma	0.000432	0.00429	CcSEcCtD
Etodolac—Gastrointestinal pain—Temozolomide—malignant glioma	0.000432	0.00429	CcSEcCtD
Etodolac—Urticaria—Temozolomide—malignant glioma	0.00042	0.00417	CcSEcCtD
Etodolac—Abdominal pain—Temozolomide—malignant glioma	0.000418	0.00415	CcSEcCtD
Etodolac—Body temperature increased—Temozolomide—malignant glioma	0.000418	0.00415	CcSEcCtD
Etodolac—Hypersensitivity—Carmustine—malignant glioma	0.000403	0.004	CcSEcCtD
Etodolac—Asthenia—Carmustine—malignant glioma	0.000392	0.00389	CcSEcCtD
Etodolac—Hypersensitivity—Temozolomide—malignant glioma	0.000389	0.00386	CcSEcCtD
Etodolac—Asthenia—Temozolomide—malignant glioma	0.000379	0.00376	CcSEcCtD
Etodolac—Diarrhoea—Carmustine—malignant glioma	0.000374	0.00371	CcSEcCtD
Etodolac—Pruritus—Temozolomide—malignant glioma	0.000374	0.00371	CcSEcCtD
Etodolac—Dizziness—Carmustine—malignant glioma	0.000362	0.00359	CcSEcCtD
Etodolac—Diarrhoea—Temozolomide—malignant glioma	0.000362	0.00359	CcSEcCtD
Etodolac—Dizziness—Temozolomide—malignant glioma	0.000349	0.00347	CcSEcCtD
Etodolac—Vomiting—Carmustine—malignant glioma	0.000348	0.00345	CcSEcCtD
Etodolac—Rash—Carmustine—malignant glioma	0.000345	0.00342	CcSEcCtD
Etodolac—Dermatitis—Carmustine—malignant glioma	0.000344	0.00342	CcSEcCtD
Etodolac—Headache—Carmustine—malignant glioma	0.000343	0.0034	CcSEcCtD
Etodolac—Vomiting—Temozolomide—malignant glioma	0.000336	0.00333	CcSEcCtD
Etodolac—Rash—Temozolomide—malignant glioma	0.000333	0.00331	CcSEcCtD
Etodolac—Dermatitis—Temozolomide—malignant glioma	0.000333	0.0033	CcSEcCtD
Etodolac—Headache—Temozolomide—malignant glioma	0.000331	0.00329	CcSEcCtD
Etodolac—Nausea—Carmustine—malignant glioma	0.000325	0.00322	CcSEcCtD
Etodolac—Nausea—Temozolomide—malignant glioma	0.000314	0.00312	CcSEcCtD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.29e-05	0.000261	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.29e-05	0.000261	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2B6—malignant glioma	3.28e-05	0.00026	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—NCOR1—malignant glioma	3.28e-05	0.00026	CbGpPWpGaD
Etodolac—ALB—Hemostasis—SOD1—malignant glioma	3.26e-05	0.000258	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.25e-05	0.000258	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—RAF1—malignant glioma	3.23e-05	0.000256	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MMP9—malignant glioma	3.23e-05	0.000256	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	3.23e-05	0.000256	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	3.22e-05	0.000255	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.2e-05	0.000254	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	3.15e-05	0.000249	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—BCHE—malignant glioma	3.1e-05	0.000245	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.08e-05	0.000244	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—SLC5A5—malignant glioma	3.06e-05	0.000242	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—ASMT—malignant glioma	3.05e-05	0.000241	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTP1—malignant glioma	3.03e-05	0.00024	CbGpPWpGaD
Etodolac—PTGS2—Disease—JAG2—malignant glioma	3.01e-05	0.000239	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—IDH1—malignant glioma	3e-05	0.000238	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	3e-05	0.000238	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PTK2—malignant glioma	2.99e-05	0.000237	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.98e-05	0.000236	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.97e-05	0.000236	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.97e-05	0.000235	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2—malignant glioma	2.96e-05	0.000235	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CAT—malignant glioma	2.95e-05	0.000234	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SPHK1—malignant glioma	2.9e-05	0.00023	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—malignant glioma	2.9e-05	0.00023	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTT1—malignant glioma	2.9e-05	0.00023	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.89e-05	0.000229	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—malignant glioma	2.87e-05	0.000228	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.87e-05	0.000227	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BCAN—malignant glioma	2.87e-05	0.000227	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.87e-05	0.000227	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP2C18—malignant glioma	2.84e-05	0.000225	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—RAF1—malignant glioma	2.84e-05	0.000225	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—MYC—malignant glioma	2.84e-05	0.000225	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTP1—malignant glioma	2.83e-05	0.000224	CbGpPWpGaD
Etodolac—ALB—Metabolism—IDH2—malignant glioma	2.82e-05	0.000224	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NCOR1—malignant glioma	2.79e-05	0.000221	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CAT—malignant glioma	2.75e-05	0.000218	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.73e-05	0.000216	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.7e-05	0.000214	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.68e-05	0.000212	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CAV1—malignant glioma	2.67e-05	0.000212	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.66e-05	0.000211	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2B6—malignant glioma	2.65e-05	0.00021	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.64e-05	0.000209	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—malignant glioma	2.61e-05	0.000207	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NCOR1—malignant glioma	2.6e-05	0.000206	CbGpPWpGaD
Etodolac—PTGS2—Disease—H3F3A—malignant glioma	2.55e-05	0.000202	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NOTCH1—malignant glioma	2.54e-05	0.000201	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—BCHE—malignant glioma	2.52e-05	0.0002	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	2.52e-05	0.0002	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PDGFB—malignant glioma	2.51e-05	0.000199	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.5e-05	0.000198	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—SLC5A5—malignant glioma	2.49e-05	0.000198	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—TNF—malignant glioma	2.49e-05	0.000197	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—KRAS—malignant glioma	2.47e-05	0.000195	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTP1—malignant glioma	2.46e-05	0.000195	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.44e-05	0.000194	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CG—malignant glioma	2.43e-05	0.000193	CbGpPWpGaD
Etodolac—ALB—Metabolism—IDH1—malignant glioma	2.43e-05	0.000192	CbGpPWpGaD
Etodolac—PTGS2—Disease—JAG1—malignant glioma	2.4e-05	0.00019	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CAT—malignant glioma	2.4e-05	0.00019	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—PPARG—malignant glioma	2.39e-05	0.00019	CbGpPWpGaD
Etodolac—ALB—Hemostasis—CAV1—malignant glioma	2.38e-05	0.000189	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.36e-05	0.000187	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.36e-05	0.000187	CbGpPWpGaD
Etodolac—PTGS2—Disease—FBXW7—malignant glioma	2.35e-05	0.000186	CbGpPWpGaD
Etodolac—ALB—Metabolism—SPHK1—malignant glioma	2.35e-05	0.000186	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PPARG—malignant glioma	2.35e-05	0.000186	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.34e-05	0.000185	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—IDH2—malignant glioma	2.31e-05	0.000183	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP2C18—malignant glioma	2.3e-05	0.000182	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTT1—malignant glioma	2.3e-05	0.000182	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CAV1—malignant glioma	2.27e-05	0.00018	CbGpPWpGaD
Etodolac—ALB—Hemostasis—FN1—malignant glioma	2.27e-05	0.00018	CbGpPWpGaD
Etodolac—ALB—Hemostasis—F2—malignant glioma	2.27e-05	0.00018	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NCOR1—malignant glioma	2.26e-05	0.000179	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.23e-05	0.000177	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.18e-05	0.000173	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2B6—malignant glioma	2.17e-05	0.000172	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CG—malignant glioma	2.17e-05	0.000172	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	2.17e-05	0.000172	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTGS1—malignant glioma	2.16e-05	0.000171	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.15e-05	0.00017	CbGpPWpGaD
Etodolac—ALB—Hemostasis—EGF—malignant glioma	2.15e-05	0.00017	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CD—malignant glioma	2.14e-05	0.000169	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PTPN11—malignant glioma	2.13e-05	0.000169	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CAV1—malignant glioma	2.12e-05	0.000168	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CG—malignant glioma	2.07e-05	0.000164	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.04e-05	0.000161	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.02e-05	0.00016	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTP1—malignant glioma	2.01e-05	0.000159	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—BCHE—malignant glioma	2e-05	0.000159	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PPARG—malignant glioma	2e-05	0.000158	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—IDH1—malignant glioma	1.99e-05	0.000157	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT2—malignant glioma	1.99e-05	0.000157	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—SLC5A5—malignant glioma	1.98e-05	0.000157	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.98e-05	0.000157	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	1.97e-05	0.000156	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAT—malignant glioma	1.95e-05	0.000155	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CG—malignant glioma	1.93e-05	0.000153	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SPHK1—malignant glioma	1.92e-05	0.000152	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CD—malignant glioma	1.91e-05	0.000151	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.91e-05	0.000151	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.88e-05	0.000149	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.87e-05	0.000148	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CB—malignant glioma	1.86e-05	0.000148	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PPARG—malignant glioma	1.86e-05	0.000148	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTT1—malignant glioma	1.86e-05	0.000147	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—malignant glioma	1.85e-05	0.000147	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—malignant glioma	1.85e-05	0.000146	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NCOR1—malignant glioma	1.85e-05	0.000146	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CAV1—malignant glioma	1.85e-05	0.000146	CbGpPWpGaD
Etodolac—PTGS2—Disease—CDKN2B—malignant glioma	1.84e-05	0.000146	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CD—malignant glioma	1.82e-05	0.000144	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.78e-05	0.000141	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.76e-05	0.00014	CbGpPWpGaD
Etodolac—PTGS2—Disease—HES1—malignant glioma	1.76e-05	0.000139	CbGpPWpGaD
Etodolac—PTGS2—Disease—NCOR1—malignant glioma	1.75e-05	0.000139	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS1—malignant glioma	1.74e-05	0.000138	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.74e-05	0.000138	CbGpPWpGaD
Etodolac—ALB—Hemostasis—RAF1—malignant glioma	1.7e-05	0.000135	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CD—malignant glioma	1.7e-05	0.000134	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.68e-05	0.000133	CbGpPWpGaD
Etodolac—PTGS2—Disease—PDGFRA—malignant glioma	1.68e-05	0.000133	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CB—malignant glioma	1.66e-05	0.000132	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PPARG—malignant glioma	1.62e-05	0.000129	CbGpPWpGaD
Etodolac—ALB—Metabolism—BCHE—malignant glioma	1.62e-05	0.000128	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.62e-05	0.000128	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.62e-05	0.000128	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—malignant glioma	1.61e-05	0.000128	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—malignant glioma	1.61e-05	0.000127	CbGpPWpGaD
Etodolac—ALB—Metabolism—SLC5A5—malignant glioma	1.6e-05	0.000127	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTP1—malignant glioma	1.59e-05	0.000126	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CB—malignant glioma	1.58e-05	0.000126	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—malignant glioma	1.57e-05	0.000124	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.56e-05	0.000124	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAT—malignant glioma	1.55e-05	0.000123	CbGpPWpGaD
Etodolac—PTGS2—Disease—TERT—malignant glioma	1.54e-05	0.000122	CbGpPWpGaD
Etodolac—PTGS2—Disease—HLA-A—malignant glioma	1.54e-05	0.000122	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—malignant glioma	1.53e-05	0.000121	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTT1—malignant glioma	1.52e-05	0.000121	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.51e-05	0.00012	CbGpPWpGaD
Etodolac—PTGS2—Disease—PDGFB—malignant glioma	1.5e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CAV1—malignant glioma	1.5e-05	0.000119	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.5e-05	0.000119	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGFR1—malignant glioma	1.5e-05	0.000119	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CB—malignant glioma	1.48e-05	0.000117	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.48e-05	0.000117	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—RAF1—malignant glioma	1.47e-05	0.000117	CbGpPWpGaD
Etodolac—PTGS2—Disease—HIF1A—malignant glioma	1.47e-05	0.000117	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NCOR1—malignant glioma	1.46e-05	0.000116	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—malignant glioma	1.46e-05	0.000116	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.44e-05	0.000114	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS1—malignant glioma	1.43e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—CAV1—malignant glioma	1.43e-05	0.000113	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.42e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CG—malignant glioma	1.37e-05	0.000109	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—malignant glioma	1.37e-05	0.000109	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MYC—malignant glioma	1.37e-05	0.000108	CbGpPWpGaD
Etodolac—PTGS2—Disease—BAD—malignant glioma	1.34e-05	0.000106	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOTCH1—malignant glioma	1.33e-05	0.000105	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—BCHE—malignant glioma	1.33e-05	0.000105	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PPARG—malignant glioma	1.32e-05	0.000105	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.31e-05	0.000104	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.31e-05	0.000104	CbGpPWpGaD
Etodolac—PTGS2—Disease—CD80—malignant glioma	1.3e-05	0.000103	CbGpPWpGaD
Etodolac—PTGS2—Disease—APC—malignant glioma	1.3e-05	0.000103	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—malignant glioma	1.3e-05	0.000103	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTP1—malignant glioma	1.29e-05	0.000102	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.29e-05	0.000102	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGF—malignant glioma	1.28e-05	0.000102	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—malignant glioma	1.28e-05	0.000101	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—malignant glioma	1.28e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTPN11—malignant glioma	1.28e-05	0.000101	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAT—malignant glioma	1.25e-05	9.94e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.24e-05	9.82e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.23e-05	9.73e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—BRAF—malignant glioma	1.22e-05	9.67e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CD—malignant glioma	1.2e-05	9.54e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CAV1—malignant glioma	1.19e-05	9.46e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT2—malignant glioma	1.19e-05	9.41e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—NCOR1—malignant glioma	1.19e-05	9.39e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CD—malignant glioma	1.14e-05	9.05e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.14e-05	9.04e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—malignant glioma	1.14e-05	9e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—malignant glioma	1.11e-05	8.82e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—KRAS—malignant glioma	1.1e-05	8.74e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—FGF2—malignant glioma	1.09e-05	8.66e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CG—malignant glioma	1.09e-05	8.62e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.07e-05	8.48e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTP1—malignant glioma	1.06e-05	8.36e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CB—malignant glioma	1.05e-05	8.32e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PPARG—malignant glioma	1.05e-05	8.32e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—malignant glioma	1.04e-05	8.24e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAT—malignant glioma	1.03e-05	8.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MDM2—malignant glioma	1.02e-05	8.1e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—RAF1—malignant glioma	1.02e-05	8.08e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—malignant glioma	1.01e-05	8.03e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—ERBB2—malignant glioma	1.01e-05	7.99e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CB—malignant glioma	9.95e-06	7.88e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—malignant glioma	9.81e-06	7.77e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NCOR1—malignant glioma	9.7e-06	7.69e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—malignant glioma	9.66e-06	7.65e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—CAV1—malignant glioma	9.66e-06	7.65e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CD—malignant glioma	9.56e-06	7.58e-05	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—malignant glioma	9.47e-06	7.5e-05	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—malignant glioma	9.28e-06	7.35e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.23e-06	7.31e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—malignant glioma	9.07e-06	7.19e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—malignant glioma	9.01e-06	7.14e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CG—malignant glioma	8.8e-06	6.97e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—malignant glioma	8.6e-06	6.81e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PPARG—malignant glioma	8.49e-06	6.73e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CB—malignant glioma	8.33e-06	6.6e-05	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—malignant glioma	8.28e-06	6.56e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CAV1—malignant glioma	7.91e-06	6.27e-05	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—malignant glioma	7.89e-06	6.25e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—malignant glioma	7.85e-06	6.22e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CD—malignant glioma	7.74e-06	6.13e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—malignant glioma	7.69e-06	6.09e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.56e-06	5.99e-05	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—malignant glioma	7.36e-06	5.83e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CG—malignant glioma	7.2e-06	5.71e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—malignant glioma	7.2e-06	5.71e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—MYC—malignant glioma	7.15e-06	5.66e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—malignant glioma	6.99e-06	5.54e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PPARG—malignant glioma	6.95e-06	5.51e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CB—malignant glioma	6.74e-06	5.34e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—malignant glioma	6.68e-06	5.29e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—KRAS—malignant glioma	6.6e-06	5.23e-05	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—malignant glioma	6.41e-06	5.08e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—malignant glioma	6.4e-06	5.07e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CD—malignant glioma	6.33e-06	5.02e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—malignant glioma	6.07e-06	4.81e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—malignant glioma	5.83e-06	4.62e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CB—malignant glioma	5.52e-06	4.37e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—malignant glioma	5.47e-06	4.33e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—malignant glioma	5.23e-06	4.14e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—malignant glioma	5.08e-06	4.03e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—malignant glioma	4.96e-06	3.93e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—malignant glioma	4.77e-06	3.78e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—malignant glioma	4.15e-06	3.29e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—malignant glioma	4.11e-06	3.26e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—malignant glioma	3.36e-06	2.67e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—malignant glioma	3.36e-06	2.66e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—malignant glioma	2.75e-06	2.18e-05	CbGpPWpGaD
